InvestorsHub Logo
Followers 0
Posts 22
Boards Moderated 0
Alias Born 01/18/2012

Re: Organic2 post# 36967

Tuesday, 01/24/2012 12:38:00 PM

Tuesday, January 24, 2012 12:38:00 PM

Post# of 129051
Alright guys... interesting thread. I'm a noob to all of this, but just want to state what I see:

1) This company only has two employees, CEO & CFO.
2) There are no scientists or pharmacists working here.
3) There is no revenue.
4) FDA has not approved any medicine made by this company.
5) This company states that they are in the "developmental" stages... meaning that it's only doing R&D (by it's sole CEO and no other scientists).
6) The $6M+ revenue expected this year is only based IF the FDA accepts the medications.
7) This is not the only company that has a "cure" for cancer. A press release just came out last week on the University of Calgary 's cure for cancer and how no news agency was picking it up because the big pharmas can't make any money on the cure... since it has no side effects (to treat with using additional medication).
8) There are many cures for cancer. There is a clinic in Japan that uses alternative therapy to cure cancer. Forget what that clinic is called.

This company is not special in the sense that they found a cure. Cures exist. But pharmas decide not to produce them because there is no money in it. It's very sad. I've had a lot of family members pass away from cancer, particularly in my wife's family.

I'm not bashing this stock. If they can do what they can do, then it's big. However, as of yet, they are still in the very early stages of research. A company like this could be in the "developmental" stage for 10 years. My mom worked for a startup pharma... it took them over 10 years just to get funding and they are still not in production mode yet.

I'm taking this stock with a grain of salt, so to speak. It is what is is... a chance to make money in the short term (next few weeks).

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.